PeptiVerse: A Unified Platform for Therapeutic Peptide Property Prediction
Zhang, Y.; Tang, S.; Chen, T.; Mahood, E.; Vincoff, S.; Chatterjee, P.
Show abstract
Therapeutic peptides combine the advantages of small molecules and antibodies, offering target flexibility and low immunogenicity, yet their successful translation requires careful evaluation of multiple developability properties beyond binding alone. As chemically modified peptides become increasingly common in drug design, no unified platform currently supports systematic property assessment across both canonical sequences and SMILES-based representations. Leveraging the generalizability of large foundational models trained on protein and chemical data, we introduce PeptiVerse, a universal therapeutic peptide property prediction platform. PeptiVerse accepts either amino acid sequences or chemically modified peptide SMILES, delivers state-of-the-art performance across diverse property prediction tasks, and provides both a web interface and open-source implementation for rapid, accessible, and scalable pep-tide developability analysis. By unifying property prediction across representations, PeptiVerse directly supports early-stage peptide therapeutic development campaigns and property-aware generative design workflows.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- InversePep: Diffusion-Driven Structure-Based Inverse Folding for Functional Peptides 94%
- ProDualNet: Dual-Target Protein Sequence Design Method Based on Protein Language Model and Structure Model 93%
- Scalable embedding fusion with protein language models: insights from benchmarking text-integrated representations 93%
Similar papers in this journal
- PepFlow: direct conformational sampling from peptide energy landscapes through hypernetwork-conditioned diffusion 94%
- Accelerating protein engineering with fitness landscape modeling and reinforcement learning 93%
- Evaluating generalizability of artificial intelligence models for molecular datasets 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.